anti-nectin-4 TRuC Treg-cell therapy (TCR2 Therapeutics)

N/A

Report date: 2025/01/26 19:19:07

Base Information

Drug Nameanti-nectin-4 TRuC Treg-cell therapy (TCR2 Therapeutics)
Drug Alias Nameanti-nectin-4 TRuC-T cell therapy (TCR2 Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionNectin-4 modulators
TargetsNectin-4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTcr2 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTcr2 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A